Adjuvants for immunotherapy: lost in translation?
van Hemelen
D
D
van Oosterhout
A J M
AJ
D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D039741:Antigens, Dermatophagoides / Q000276:immunology / Q000627:therapeutic use; D001249:Asthma / Q000276:immunology / Q000628:therapy; D002648:Child; D002762:Cholecalciferol / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D003131:Combined Modality Therapy / Q000379:methods; D016207:Cytokines / Q000378:metabolism; D003888:Desensitization, Immunologic / Q000379:methods*; D051858:Forkhead Transcription Factors / Q000378:metabolism; D005938:Glucocorticoids / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007107:Immune System / Q000187:drug effects / Q000276:immunology; D016032:Randomized Controlled Trials as Topic; D050378:T-Lymphocytes, Regulatory / Q000276:immunology / Q000378:metabolism; D057170:Translational Research, Biomedical
D000276:Adjuvants, Immunologic; D039741:Antigens, Dermatophagoides; D016207:Cytokines; C418974:FOXP3 protein, human; D051858:Forkhead Transcription Factors; D005938:Glucocorticoids; D002762:Cholecalciferol